文献速递青光眼小儿眼科与斜弱视

疑似原发性先天性青光眼个体中FOXC1变异的患病率

Prevalence of FOXC1 Variants in Individuals With a Suspected Diagnosis of Primary Congenital Glaucoma.
PubMed 文献 · JAMA Ophthalmol · 2019-01-01

该研究纳入澳大利亚和意大利两个队列共131例疑似原发性先天性青光眼个体,采用外显子测序联合Sanger测序和多重连接依赖探针扩增检测FOXC1变异,发现8例(6.1%)携带罕见预测有害FOXC1变异,所有携带者均有至少一项Axenfeld-Rieger综合征相关眼部和/或全身特征。

要点

  • 疑似原发性先天性青光眼中FOXC1变异检出率为6.1%(8/131)。
  • 所有FOXC1变异携带者均存在Axenfeld-Rieger综合征相关特征。
  • 建议基因 panel 纳入FOXC1作为诊断辅助,尤其临床特征轻微时。

核心结论

  • 疑似原发性先天性青光眼个体中可检出FOXC1变异,支持将FOXC1纳入诊断基因panel。
  • 儿童青光眼具有遗传和表型异质性,Axenfeld-Rieger综合征临床特征可能轻微。

研究设计与样本

  • 研究纳入澳大利亚和意大利两个队列,招募时间为2007年1月1日至2016年3月1日。
  • 共纳入131例由治疗专科医生诊断为疑似原发性先天性青光眼的个体。
  • 采用外显子测序联合Sanger测序和多重连接依赖探针扩增检测FOXC1变异。

主要发现

  • 131例中8例(6.1%)检出罕见预测有害FOXC1变异;若包括由CYP1B1变异解释的病例,则为166例中8例(4.8%)。
  • 澳大利亚队列84例中37例(44.0%)为女性,71例(84.5%)为欧洲 ancestry;招募时平均(SD)年龄24.3(18.1)岁。
  • 意大利队列47例中21例(44.7%)为女性,45例(95.7%)为欧洲 ancestry;招募时平均(SD)年龄22.5(18.4)岁。
  • 经复查或重新调查,所有FOXC1变异携带者均至少有1项可检测到的Axenfeld-Rieger综合征相关眼部和/或全身特征。

临床怎么用

  • 对疑似原发性先天性青光眼患者,可考虑基因检测纳入FOXC1以辅助诊断。
  • 即使Axenfeld-Rieger综合征临床特征轻微,也应警惕FOXC1变异可能。

局限性

  • 结果需要进一步复制以支持此类基因panel的未来应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Both primary and secondary forms of childhood glaucoma have many distinct causative mechanisms, and in many cases a cause is not immediately clear. The broad phenotypic spectrum of secondary glaucoma, particularly in individuals with variants in FOXC1 or PITX2 genes associated with Axenfeld-Rieger syndrome, makes it more difficult to diagnose patients with milder phenotypes. These cases are occasionally classified and managed as primary congenital glaucoma. OBJECTIVE: To investigate the prevalence of FOXC1 variants in participants with a suspected diagnosis of primary congenital glaucoma. DESIGN, SETTING, AND PARTICIPANTS: Australian and Italian cohorts were recruited from January 1, 2007, through March 1, 2016. Australian individuals were recruited through the Australian and New Zealand Registry of Advanced Glaucoma and Italian individuals through the Genetic and Ophthalmology Unit of l'Azienda Socio-Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda in Milan, Italy. We performed exome sequencing, in combination with Sanger sequencing and multiplex ligation-dependent probe amplification, to detect variants of FOXC1 in individuals with a suspected diagnosis of primary congenital glaucoma established by their treating specialist. Data analysis was completed from June 2015 to November 2017. MAIN OUTCOME AND MEASURES: Identification of single-nucleotide and copy number variants in FOXC1, along with phenotypic characterization of the individuals who carried them. RESULTS: A total of 131 individuals with a suspected diagnosis of primary congenital glaucoma were included. The mean (SD) age at recruitment in the Australian cohort was 24.3 (18.1) years; 37 of 84 Australian participants (44.0%) were female, and 71 of 84 (84.5%) were of European ancestry. The mean (SD) age at recruitment was 22.5 (18.4) years in the Italian cohort; 21 of 47 Italian participants (44.7%) were female, and 45 of 47 (95.7%) were of European ancestry. We observed rare, predicted deleterious FOXC1 variants in 8 of 131 participants (6.1%), or 8 of 166 participants (4.8%) when including those explained by variants in CYP1B1. On reexamination or reinvestigation, all of these individuals had at least 1 detectable ocular and/or systemic feature associated with Axenfeld-Rieger syndrome. CONCLUSIONS AND RELEVANCE: These data highlight the genetic and phenotypic heterogeneity of childhood glaucoma and support the use of gene panels incorporating FOXC1 as a diagnostic aid, especially because clinical features of Axenfeld-Rieger syndrome can be subtle. Further replication of these results will be needed to support the future use of such panels.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Siggs OM, Souzeau E, Pasutto F, et al. Prevalence of FOXC1 Variants in Individuals With a Suspected Diagnosis of Primary Congenital Glaucoma. JAMA Ophthalmol. 2019. PMID: 30653210. doi:10.1001/jamaophthalmol.2018.5646

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。